Stem cell therapy for chronic radiation proctitis
Treatments studied
Part of Digestive system, Injuries & trauma clinical trials.
This trial tests a new stem cell treatment for chronic radiation proctitis, a condition where the rectum is damaged from radiation therapy. The study will see how these cells spread in your body and if they can help heal the damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had radiation therapy for a pelvic cancer (like rectal, cervical, or prostate cancer).
- You have ongoing rectal symptoms (bleeding, pain, or diarrhea) that started more than 6 months after completing radiation.
- These symptoms were confirmed by a colonoscopy and haven't improved with standard treatments.
- You are generally well enough to carry out daily activities (you are not bedridden).
- You agree to use effective birth control and not plan a pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
This study looks at how different types of chronic radiation enteropathy, a bowel condition caused by radiation therapy, are linked to patient outcomes. It may help doctors better predict how the condition progresses.
This study tests whether a new cell therapy can help people with long-term intestinal damage caused by pelvic or abdominal radiation. It aims to reduce symptoms like diarrhea, pain, or bleeding and improve quality of life.
This study tests whether a fecal (stool) transplant can help heal rectal damage caused by pelvic radiation. The treatment may decrease bleeding and improve symptoms for people whose supportive care hasn't worked well.
This trial tests a shorter course of radiation therapy followed by a combination of chemotherapy, immunotherapy, and a pain-relief medication, compared to the standard approach. It is for people with a certain type of rectal cancer that has not spread.
This trial studies a combination of SBRT (a precise kind of radiation) and an immunotherapy drug (PD-1 antibody) for people whose rectal cancer has come back in the pelvis and cannot be removed by surgery. The goal is to see if this treatment can shrink the tumor or stop it from growing.
Hear when a new Radiation Proctitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.